Peripheral Artery Disease (PAD) Clinical Trials

9 recruiting

Peripheral Artery Disease (PAD) Trials at a Glance

9 actively recruiting trials for peripheral artery disease (pad) are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Ankara, Arlington, and Atlanta. Lead sponsors running peripheral artery disease (pad) studies include Emory University, Gazi University, and Cagent Vascular LLC.

Browse peripheral artery disease (pad) trials by phase

Treatments under study

About Peripheral Artery Disease (PAD) Clinical Trials

Looking for clinical trials for Peripheral Artery Disease (PAD)? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peripheral Artery Disease (PAD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peripheral Artery Disease (PAD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Detecting Peripheral Artery Disease With the Pulse

Peripheral Artery Disease (PAD)
University of Nebraska40 enrolled1 locationNCT07226193
Recruiting

Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease

Peripheral Artery Disease (PAD)
Gazi University24 enrolled1 locationNCT07169045
Recruiting

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Peripheral Artery Disease (PAD)
The University of Texas at Arlington120 enrolled2 locationsNCT07313410
Recruiting
Not Applicable

Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome

Diabetes MellitusStrokeChronic Kidney Disease(CKD)+4 more
Universidade do Porto150 enrolled1 locationNCT07173062
Recruiting
Not Applicable

Exercise Activity to Improve Mobility in Patients With CKD and PAD

Chronic Kidney Disease Stage 3 and 4Peripheral Artery Disease (PAD)
University Hospital of Ferrara124 enrolled3 locationsNCT06621264
Recruiting

Serranator POINT FORCE Registry

Peripheral Artery Disease (PAD)Dysfunctional AV FistulaDysfunctional AV Graft
Cagent Vascular LLC500 enrolled1 locationNCT06687590
Recruiting
Not Applicable

Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)

Peripheral Artery Disease (PAD)
Zhejiang Zylox Medical Device Co., Ltd.130 enrolled1 locationNCT06605209
Recruiting

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

Chronic Limb Threatening IschemiaPeripheral Artery Disease (PAD)
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology130 enrolled1 locationNCT06713850
Recruiting
Phase 2

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Peripheral Artery Disease (PAD)
Emory University176 enrolled1 locationNCT03304821